Heidelberg Registry of Atrial Fibrillation
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 12,297
- 试验地点
- 1
- 主要终点
- all-cause mortality
研究概览
简要总结
The single-center HERA AFIb registry was created to assess real-world prevalence, demographic characteristics and management of patients with atrial fibrillation (AF) in the era of novel oral anticoagulant regimes (NOAC) presenting in the emergency department (ED) of University of Heidelberg
详细描述
HERA AFIb is a single-center retrospective registry which enrolled consecutive cases presenting with atrial fibrillation at the emergency department of University Hospital of Heidelberg. Clinical parameters and characteristics for cases were assessed retrospectively. Follow-up was performed via review of medical reports, phone calls and postal queries. Outcome parameters included rates for all-cause mortality, non-hemorrhagic stroke, myocardial infarction and major bleeding.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •documented atrial fibrillation
- •availability of at least one hsTnT measurement
排除标准
- •lost to follow-up
结局指标
主要结局
all-cause mortality
时间窗: 24 months
all-cause mortality during follow-up
次要结局
- major bleeding(24 months)
- ischaemic stroke(24 months)
- myocardial infarction(24 months)
研究者
Mustafa Yildirim
Principle investigator
University Hospital Heidelberg